PD-L1-expressing sEVs can reportedly promote cancer progression by suppressing patient immunity in vitro and in vivo20,21, and suppressing the secretion of PD-L1-expressing sEVs from cancer cells restores immunity and prolongs survival21. The gene discussed is CD274; the disease is cancer.